Blood Pressure - From Bench to Bed 2018
DOI: 10.5772/intechopen.73640
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Resistant Hypertension: An Update in Device Therapy

Abstract: Hypertension is the most prevalent cardiac risk factor. In the United some estimates show 60% of 60-year-olds, 70% of 70-year-olds, an 80% of 80-year-olds being hypertensive. Often, blood pressure becomes resistant or refractory. Device therapy represents a new approach to treating this disease. The best studied of these nonpharmacologic approaches to resistant/refractory hypertension include renal denervation, carotid sinus stimulators, and central arteriovenous fistula placement. This chapter will focus on n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 31 publications
(29 reference statements)
0
2
0
Order By: Relevance
“…Upon investigation of its toxicity, the International Agency for Research on Cancer (IARC) has classified AFM1 as a group 1 human carcinogen [21,22,23]. The secretion of AFM1 in milk varies widely according to different factors including animal species, season and milking time, level of AFB1 intake, and volume of milk produced by the mammal in question [24,25,26]. Once in milk, AFM1 is not degraded and can resist different industrial treatments including milk sterilization or pasteurization, in addition to any other heat treatments [27,28,29,30,31].…”
Section: Introductionmentioning
confidence: 99%
“…Upon investigation of its toxicity, the International Agency for Research on Cancer (IARC) has classified AFM1 as a group 1 human carcinogen [21,22,23]. The secretion of AFM1 in milk varies widely according to different factors including animal species, season and milking time, level of AFB1 intake, and volume of milk produced by the mammal in question [24,25,26]. Once in milk, AFM1 is not degraded and can resist different industrial treatments including milk sterilization or pasteurization, in addition to any other heat treatments [27,28,29,30,31].…”
Section: Introductionmentioning
confidence: 99%
“…Alginates are derived from brown seaweed and are produced mainly in the USA, Norway, China, Canada, France, and Japan [139]. Among the advantages of obtaining alginate from brown algae is that most alginophytes have large quantities of the product and generate large areas on the rocky shores with little depth [140,141]. Figure 2 shows the areas where some algae used for alginate production are found throughout the world [142].…”
Section: Alginate Produced By Brown Algaementioning
confidence: 99%